Archives for February 1, 2019

← 2019

A Game of Partnerships: How does the BMS-Celgene merger affect the CRO space?

01-Feb-2019

By Melissa Fassbender

CRO stock prices fell initially following the news that Bristol-Myers Squibb was acquiring Celgene in a deal valued at $74bn. However, is 2019’s first mega-merger really a threat to service providers?

Next step in personalized medicine enabled by 3D printing

01-Feb-2019

By Maggie Lynch

As 3D printing technology continues to develop, it is becoming more disruptive to the pharmaceutical manufacturing industry as its value in drug delivery becomes apparent, according to IDTechEx.